BSEM News and Press, BioStem Technologies Inc From 05/01/25

Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three accepted scientific posters will feature BioStem’s advanced allograft portfolio POMPANO BEACH, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- ...

POMPANO BEACH, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it will release its first quarter 2025 fina...

POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, is pleased to announce that its Chief Executive Off...

2025-04-14 19:03:54 ET BioStem Technologies, Inc. (BSEM) Q4 2024 Earnings Conference Call April 14, 2025 04:30 PM ET Company Participants Adam Holdsworth - Investor Relations Jason Matuszewski - Chief Executive Officer Michael Fortunato - Chief Financial Officer ...

2025-04-14 16:17:51 ET More on BioStem Technologies BioStem Technologies: Building On Advanced Wound Care Needs Seeking Alpha’s Quant Rating on BioStem Technologies Historical earnings data for BioStem Technologies Financial information for BioStem Tec...

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter of profitability Prelimi...

Goldman Sachs Group Inc. (The) (GS) is expected to report $12.71 for Q1 2025 Kestra Medical Technologies Ltd. (KMTS) is expected to report for Q1 2024 AstroNova Inc. (ALOT) is expected to report for Q4 2025 Pinnacle Financial Partners Inc. (PNFP) is expected to report $1.81 for Q1 202...

POMPANO BEACH, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that it will release its fourth quarter and...

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces it has filed for an extension to submit ...

POMPANO BEACH, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced that the United States Patent and T...